蜜桃传媒

Director of Cancer Screening and Survivorship, Roswell Park Cancer Institute Areas of expertise: Lung cancer, cancer screening, cancer early detection, epidemiology, cancer prevention

After obtaining his MD degree from the Autonomous University Barcelona, Dr. Llor trained in basic research and Internal Medicine at the University of Chicago and completed his GI fellowship at the University of Illinois at Chicago. He complemented his training with a PhD degree in molecular biology from the University of Barcelona. A clinically active gastroenterologist, Dr. Llor’s research and clinical interests relate to colorectal cancer. He has a very active basic and translational research program mainly focusing on two different aspects of colorectal cancer: hereditary and familial forms, and disparities in colorectal cancer. This work has resulted in almost 100 scientific publications in this field. He has made seminal contributions to the field of Lynch syndrome diagnosis as well as in the definition of other non-polyposis syndromic colorectal cancer cases. Some of his most recent work is providing important clues to the understanding of the biological differences that contribute to disparities in colorectal cancer. Watch a video with Dr. Xavier Llor >> Dr. Llor is the Co-Director of the Smilow Cancer Genetics and Prevention Program; Director for Cancer Screening; and Medical Director of the Colorectal Cancer Prevention Program at Yale University and Smilow Cancer Hospital and he sees patients at Yale. He is a member of the steering committee of the National Colorectal Cancer Round Table (NCCRT) and member of the National Comprehensive Cancer Network (NCCN) guidelines panels for colorectal cancer screening and colorectal cancer genetics. He is commonly invited to lecture in colorectal cancer genetics in the US and abroad.

Dr. Richman is a general internist and health services researcher. Her research interests explore the use, effectiveness, and value of preventive services. She has a specific interest in cancer screening and her current work focuses on evaluating new breast cancer screening technologies as well as use and implementation of lung cancer screening.